GHRS
#2074
GH Research PLC - Ordinary Shares
29.1 3 USD
+0.08%
Sektor: Gesundheitswesen
Basis: USD
Gewinnwährung: USD
Tagesspanne
Jahresspanne
Tagesänderung
+8.21%
Monatliche Änderung
+32.47%
6 month change
+76.01%
Jahresänderung
+105.72%
Vorheriger Schlusskurs
26.9 2
Open
29.1 3
Tief
29.1 3
High
29.1 3
Volumen
31
Financials
- Market Capitalization 1.81 B
- Employee 73
- Founded 2018
- CEO Theis Terwey
- Website www.ghres.com
- Headquarter Ireland
- FIGI N/A
- Industry Biotechnologie
Related tickers
| # | Name | Preis | 24h % | 7d % | 1M % | 1J % | Marktkapitalisierung | Letzte 7 Tage | |
|---|---|---|---|---|---|---|---|---|---|
| 2069 |  BCAX Bicara Therapeutics Inc. - Common Stock | 27.60 USD | -1.85% | -7.01% | +18.25% | +91.14% | 1.81 B USD | ||
| 2070 |  STOK Stoke Therapeutics, Inc. - Common Stock | 29.11 USD | -2.67% | -11.33% | -5.85% | +125.14% | 1.81 B USD | ||
| 2079 |  ZBIO Zenas BioPharma, Inc. - Common Stock | 28.24 USD | -3.98% | -4.04% | +49.18% | +6.73% | 1.78 B USD | ||
| 2087 |  ZYME Zymeworks Inc. - Common Stock | 24.19 USD | -1.91% | -10.84% | +3.64% | +36.36% | 1.77 B USD |